Printer Friendly
The Free Library
19,595,260 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

AstraZeneca Licenses Symyx Software.


SANTA CLARA Santa Clara, city, Cuba
Santa Clara (sän`tä klä`rä), city (1994 est. pop. 217,000), capital of Villa Clara prov., central Cuba.
, Calif. -- Symyx Technologies Symyx Technologies NASDAQ: SMMX is a pioneer in the area of combinatorial chemistry applied to heterogeneous catalysis and homogeneous catalysis, polymer formulations, electronic and magnetic materials. , Inc. (Nasdaq:SMMX) announced today that AstraZeneca (NYSE NYSE

See: New York Stock Exchange
:AZN AZN Asian ) has entered into an expanded agreement to license Symyx Software electronic laboratory notebook (ELN Noun 1. ELN - a Marxist terrorist group formed in 1963 by Colombian intellectuals who were inspired by the Cuban Revolution; responsible for a campaign of mass kidnappings and resistance to the government's efforts to stop the drug trade; "ELN kidnappers target ) applications and Web Services (1) Loosely, any online service delivered over the Web. Such usage appears in articles from non-technical sources, but not in IT-oriented publications, because definition #2 below describes the correct use of the term.  for use in AstraZeneca's Global Process Research and Development (GPR&D) function. Symyx will also provide maintenance services. AstraZeneca is the fifth global pharmaceutical company to adopt Symyx Software ELN applications broadly.

"Our experience with Symyx Software convinced us that we could apply it to achieve a sustained increase in our productivity," said David Haywood, Vice President of GPR&D, AstraZeneca. "This improvement will result from the software's ability to take laboratory data from both automated and manual processes and integrate it into one searchable repository, regardless of source, location or type of information. We also appreciate that Symyx Software provides a user interface which can be tailored specifically to different requirements across GPR&D."

Paul Nowak, executive vice president and chief operating officer Chief Operating Officer (COO)

The officer of a firm responsible for day-to-day management, usually the president or an executive vice-president.
 of Symyx, said, "We are pleased that AstraZeneca has chosen our software for its Global Process R&D function. This deployment will increase access to laboratory information, and should immediately result in improved decision-making for this critical part of the AstraZeneca process development organization."

Over 40 organizations around the world use Symyx Software, including many leading pharmaceutical, biotech, chemical and energy companies.

About Symyx

Symyx Technologies, Inc. is dedicated to helping customers maximize the effectiveness and success of their research & development programs. Symyx develops and applies high-throughput research technologies and research software for customers in the pharmaceutical, chemical, energy, electronics and other industries. Symyx performs research for customers using proprietary technologies to discover new and innovative materials, sells automated high-throughput instrumentation and licenses software for use in customers' own laboratories, and licenses discovered materials, sensors and intellectual property. Symyx has the largest portfolio of patents in the field of high-throughput materials discovery, with 290 issued patents and 380 patent applications on file worldwide. Information about Symyx, including reports and other information filed by Symyx with the Securities and Exchange Commission, is available at www.symyx.com.

About AstraZeneca

AstraZeneca is a major international healthcare business engaged in the research, development, manufacture and marketing of prescription pharmaceuticals and the supply of healthcare services. It is one of the world's leading pharmaceutical companies with healthcare sales of over $21.4 billion and leading positions in sales of gastrointestinal, cardiovascular, respiratory, oncology and neuroscience products. AstraZeneca is listed in the Dow Jones Dow Jones

the best known of several U.S. indexes of movements in price on Wall Street. [Am. Hist.: Payton, 202]

See : Finance
 Sustainability Index (Global) as well as the FTSE FTSE

A company that specializes in index calculation. Although not part of a stock exchange, co-owners include the London Stock Exchange and the Financial Times.

Notes:
The FTSE is similar to Standard & Poor's in the United States.
4Good Index. For more information about AstraZeneca, please visit: www.astrazeneca.com.
COPYRIGHT 2006 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Mar 27, 2006
Words:424
Previous Article:Superior Canadian Resources Inc.: Sim Lake Drilling Program has Commenced.
Next Article:Info Support Launches Communication and Collaboration Services With Ensim Unify; Leading ICT Service Provider Launches Multiple Hosted Solutions for...
Topics:



Related Articles
Symyx Technologies Announces Delivery of Discovery Tools System to Merck.
Symyx Technologies Announces Delivery of Discovery Tools System to Lilly.
Symyx Technologies Announces Discovery Tools Agreements with Merck.
Symyx Technologies Enters into Discovery Tools and Renaissance Software Licensing Agreement with Pfizer.
Symyx Technologies Reports 2005 First Quarter Financial Results.
Symyx Technologies Announces Deployment of Symyx Renaissance Software at Pfizer.
Symyx Technologies Appoints New Director and Chairperson of Audit Committee.
Symyx Announces New Version of Symyx Software.
Symyx Technologies Releases New Version of Symyx Software Discovery Notebook.
Symyx Advances Vision for the Future of R&D at 4th Annual Symposium.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles